title: [Final height (FH) in Turner syndrome (TS): experience of 76 cases followed at the Pediatric Endocrinology Unit, Hospital de Clinicas, Federal University of Paraná].
abstract: OBJECTIVE
  To report the final height (FH) of 76 patients with Turner syndrome (TS).
  
  
  METHODS
  Review of the files and calculation of z scores: of target height (TH), and FH according to NCHS/CDC/2000 and FH according to Lyon and cols.
  
  
  RESULTS
  Patients were classified in three groups: A (n = 16), treatment with estrogens and progestogens; B (n = 21), treatment with oxandrolone (OX); C (n = 39), growth hormone (GH) plus OX. The z score of TH was not different among the groups and z score of FH was not different between A e B. Z score of FH of group C was greater than the other groups, > 2SDS of Lyon's curve and fitted on the 3(rd) percentile of NCHS/CDC. Multiple regression analysis showed type of treatment (p < 0.001) and maternal height (p = 0.02) as most influencing factors on FH.
  
  
  CONCLUSIONS
  GH plus OX and maternal height contributed significantly to enhance FH of TS patients.
authors: Departamento de Pediatria, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brasil. drana_endo@yahoo.com.br
authors: Ana Vládia Ramos
authors: AV
authors: Fonteles
authors: Roberta Savaris
authors: RS
authors: Dondoni
authors: Margaret Cristina da Silva
authors: MC
authors: Boguszewski
authors: Suzana
authors: S
authors: Nesi-França
authors: Rosana
authors: R
authors: Marques-Pereira
authors: Romolo
authors: R
authors: Sandrini Neto
authors: Luiz de
authors: Ld
authors: Lacerda Filho
mesh_terms: D000293:Adolescent; D000365:Age Determination by Skeleton; D000728:Androgens / Q000627:therapeutic use*; D001827:Body Height / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D010074:Oxandrolone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*; D011627:Puberty / Q000502:physiology; D012044:Regression Analysis; D016896:Treatment Outcome; D014424:Turner Syndrome / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000728:Androgens; D004967:Estrogens; D011372:Progestins; D019382:Human Growth Hormone; D010074:Oxandrolone